SkinHealth Systems Inc. Reports Decline in Financial Performance for Q2 2026

SkinHealth Systems Inc. reported a decline in financial performance for the second quarter of 2026, with net sales totaling $72.1 million, a decrease of 7.8% from $78.2 million in the same period last year. The company's gross profit remained relatively stable at $49.3 million, compared to $49.1 million in the prior year, resulting in an improved gross margin of 68.4%, up from 62.8%. However, the company recorded a net loss of $2.7 million, contrasting sharply with a net income of $19.7 million in the second quarter of 2025. This shift in profitability was attributed to increased interest expenses and a significant drop in other income, which included a prior year gain from the exchange of convertible notes.

In the first half of 2026, total net sales reached $137 million, down 7.3% from $147.8 million in the same period of 2025. The decline was driven by a 13.6% drop in sales of Delivery Systems, which fell to $36.8 million, and a 4.7% decrease in Consumables sales, totaling $100.2 million. The company cited unfavorable macroeconomic conditions and credit constraints as key factors impacting sales across all regions. Notably, the Americas accounted for the largest share of sales, generating $94.5 million in the first half of 2026, although this was also down from the previous year.

Operationally, SkinHealth Systems has made strategic adjustments, including transitioning its sales operations in Australia and New Zealand to a distributor model, which is expected to enhance long-term profitability despite a reduction in revenue. The company has also focused on reducing operating expenses, which fell to $92 million in the first half of 2026 from $112.4 million in the same period last year. This reduction was primarily due to lower personnel-related costs and decreased legal and professional fees, although it was partially offset by expenses related to a proposed settlement in a securities class action lawsuit.

As of June 30, 2026, SkinHealth Systems reported total assets of $486.6 million, down from $499.8 million at the end of 2025. The company’s cash and cash equivalents decreased to $206.1 million, reflecting a net cash outflow from operating activities of $2.9 million during the first half of the year. The company continues to manage its liquidity carefully, with plans to address the maturity of its 2026 convertible notes using cash on hand. Looking ahead, SkinHealth Systems remains cautious about the macroeconomic environment, including inflation and potential recessions, which could further impact its financial performance and operational strategies.